Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company RNL Bio Co. Ltd.
DescriptionHuman adipose mesenchymal stem cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat Buerger's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today